GeminIQ Website Logo

Viewing LIANY free

Subscribe for full history, 90+ metrics, screener, watchlist...

LianBio

LIANY

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1031041027979134140228109
Marketable Securities Current
149163184223233195229155-
Due From Related Parties Current
------2--
Prepaid Expense And Other Assets Current
5599579106
Other Receivables Net Current
111277666
Assets Current
258273296313324344386400121
Restricted Cash Noncurrent
00002020202020
Property Plant And Equipment Net
233333321
Operating Lease Right Of Use Asset
334445450
Other Assets Noncurrent
000000000
Assets
263279303320352372413426142
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
625121832
Accrued Liabilities Current
161717201818151013
Operating Lease Liability Current
222222110
Accrual For Taxes Other Than Income Taxes Current
--------6
Other Liabilities Current
212001112
Liabilities Current
262226242222251522
Operating Lease Liability Noncurrent
112234340
Other Liabilities Noncurrent
00000000-
Liabilities
272328264546493942
Temporary Equity Carrying Amount Attributable To P…
-------0353
Stockholders Equity Inclu…
Common Stock Value
000000000
Additional Paid In Capital Common Stock
74674173773272972472071342
Accumulated Other Comprehensive Income Loss Net Of…
-3-3-2-2-4-1-110
Retained Earnings Accumulated Deficit
-540-516-495-471-452-430-388-360-339
Stockholders Equity
236222274260307326331387-253
Minority Interest
343434343434343444
Liabilities And Stockholders Equity
263279303320352372413426142
Common Stock Par Or Stated Value Per Share
000000000
Common Stock Shares Authorized
2,9242,9242,9242,9242,9242,9242,9242,9242,859
Common Stock Shares Issued
10710710710710810810710722
Redeemable Convertible Preferred Stock
-------0-
Shares Outstanding
10710710710710810810710722
Temporary Equity Shares Outstanding
-------0-

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20239.09%3.64%-8.18%-10.11%-20.21%114.36%-1.91%-0.48%-1.43%---
202225.54%-1.30%-0.87%-8.43%-23.37%-49.04%15.44%20.59%88.97%30.30%70.91%50.91%
2021-------29.10%-14.34%-23.57%35.85%-33.69%-34.77%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
10.06
12.62
11.42
13.24
14.72
15.80
15.35
26.48
5.44
Quick Ratio
9.88
12.40
11.09
12.88
14.49
15.48
14.99
25.79
5.16
Working Capital
232.18M
251.46M
270.13M
289.16M
302.21M
321.96M
360.98M
384.56M
98.74M
Leverage & Debt
Debt to Equity
0.11
0.11
0.10
0.09
0.15
0.14
0.15
0.10
-0.17
Interest Coverage TTM
-10.71
-12.12
-19.06
-29.01
-113.57
-248.26
-
-
-
Debt Ratio
0.10
0.08
0.09
0.08
0.13
0.12
0.12
0.09
0.30
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
-0.82
-0.80
-0.99
-1.02
-2.54
-2.47
-
-
-
Free Cash Flow Per Share TTM
-0.78
-0.79
-0.98
-0.94
-0.93
-2.02
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Growth Metrics
Net Income Growth (1Y)
-68.03%
-67.78%
-
-
-
-
-
-
-
EPS Growth (1Y)
-67.68%
-67.55%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
P/B TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-
Market Cap
-100.61K
-153.96K
-132.35K
-111.52K
-136.55K
-146.88K
-250.78K
-133.50K
-
Enterprise Value
-103.56M
-104.28M
-102.54M
-79.41M
-99.07M
-154.56M
-140.11M
-228.32M
-
Calculated Values
Free Cash Flow TTM
-83.99M
-84.87M
-105.24M
-101.03M
-101.25M
-218.08M
-
-
-
Net Debt
-103.46M
-104.13M
-102.41M
-79.29M
-98.93M
-154.41M
-139.86M
-228.18M
-109.02M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-01-02Sale
Owner: Gu, Ehong
Title: Interim CFO
Shares: 1,731
Price/Share: $4.34
Value: $7,512.54
Shares Owned: 76,762
Relationship: Officer
Ownership: Direct
2023-01-03Sale
Owner: Qian, Jiang
Title: SVP, China General Manager
Shares: 2,239
Price/Share: $1.65
Value: $3,694.35
Shares Owned: 67,349
Relationship: Officer
Ownership: Direct
2022-08-18Purchase
Owner: Lev, Lb Holdings Gp, Llc,…
Title: -
Shares: 998,240
Price/Share: $2.40
Value: $2,395,776.00
Shares Owned: 3,728,491
Relationship: Director,TenPercentOwner
Ownership: Indirect
2022-05-26Purchase
Owner: Lev, Lb Holdings, Lp, Per…
Title: -
Shares: 69,000
Price/Share: $3.13
Value: $215,970.00
Shares Owned: 2,730,251
Relationship: Director,TenPercentOwner
Ownership: Indirect
2022-05-25Purchase
Owner: Perceptive, Venture Advis…
Title: -
Shares: 120,000
Price/Share: $2.63
Value: $315,600.00
Shares Owned: 2,661,251
Relationship: Director,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2023-12-31
75.24%
Inst. Shares: 80,630,051
Shares Outstanding: 107,167,691
2023-09-30
66.82%
Inst. Shares: 71,610,429
Shares Outstanding: 107,167,691
2023-06-30
67.82%
Inst. Shares: 72,683,358
Shares Outstanding: 107,164,401
2023-03-31
63.96%
Inst. Shares: 68,543,988
Shares Outstanding: 107,162,025
2022-12-31
68.02%
Inst. Shares: 73,413,831
Shares Outstanding: 107,923,296

LianBio (LIANY) — SEC Financial Statements & Analysis

LianBio (LIANY) is a pharmaceutical preparations company, incorporated in E9. LianBio trades on OTC as: LIANY. Based on its latest SEC filing (Form 10-Q, period ending 2023-09-30), LianBio reported a Debt-to-Equity ratio of 0.11x, a Price-to-Book (P/B) ratio of -0.00x (TTM), at a market cap of $-100.61K. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.11x
P/B TTM
-0.00x
Market Cap
$-100.61K

Data as of 2023-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LianBio in?

LianBio (LIANY) operates in the Pharmaceutical Preparations industry.

What is LIANY's market cap?

LianBio (LIANY) has a market capitalization of $-100.61K as of 2023-09-30.

What is LIANY's P/E ratio?

LianBio (LIANY)'s trailing twelve month P/E ratio is 0.00x as of 2023-09-30.

What exchange does LIANY trade on?

LianBio (LIANY) trades on the OTC.

Where is LianBio incorporated?

LianBio is incorporated in Cayman Islands.

Wall Street's data.
Main Street's price.